We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

196 hedge funds and large institutions have $3.49B invested in ChemoCentryx, Inc. in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 65 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 65

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

14% more capital invested

Capital invested by funds: $3.06B → $3.49B (+$429M)

4% less funds holding

Funds holding: 204196 (-8)

19% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 36

49% less call options, than puts

Call options by funds: $21.2M | Put options by funds: $41.3M

Holders
196
Holders Change
-8
Holders Change %
-3.92%
% of All Funds
3.47%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.11%
New
29
Increased
79
Reduced
65
Closed
36
Calls
$21.2M
Puts
$41.3M
Net Calls
-$20.2M
Net Calls Change
-$45.2M

CCXI Hedge Fund Activity: Q4 2020 in Review

196 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2020, worth a combined $3.49B — up 14% from $3.06B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of CCXI and 29 opened new positions — a net loss of 7 holders — while 65 trimmed existing stakes and 79 added.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $43.3M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $37.2M sold.

  • 196 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2020, down from 204 in Q3 2020.
  • Funds reported $3.49B of ChemoCentryx, Inc. stock for Q4 2020, up 14% quarter-over-quarter.
  • 29 funds opened new ChemoCentryx, Inc. positions in Q4 2020 and 36 closed out, a net change of -7 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2020 was Avidity Partners Management, an estimated $43.3M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2020 was Point72 Asset Management, an estimated $37.2M sold.

Based on aggregated 13F filings for Q4 2020.